Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Psychiatry Res ; 174(3): 163-70, 2009 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-19914044

RESUMO

Acute ethanol administration increases striatal dopamine release and decreases cerebral glucose metabolism. The A1 allele of the ANKK1 TaqIa polymorphism is associated with lower dopaminergic tone and greater risk for alcoholism, but the mechanisms are unclear. We hypothesized that ethanol would be more reinforcing in men with the A1 allele (A1+) than in men without it (A1-), as indicated by decreased anxiety and fatigue and altered activity in associated brain regions. In a pilot study, A1+ and A1- men (6/group) drank ethanol (0.75 ml/kg) or placebo beverages on each of 2 days. Positron emission tomography with [F-18]fluorodeoxyglucose (FDG) was used to assess regional cerebral glucose metabolism as a measure of relative brain activity while participants performed a vigilance task. Significant findings were as follows: Ethanol decreased anxiety and fatigue in A1+ men but increased them in A1- men. Ethanol increased activity in the striatum and insula of A1+ men, but reduced activity in the anterior cingulate of A1- men. Reduced anxiety and fatigue in A1+ men were significantly associated with greater activity within a right orbitofrontal region previously implicated in cognitive control, and less activity in structures associated with anxiety (amygdala), fatigue (thalamus), and craving/reinforcement (striatum). In contrast, anxiety and fatigue changes were unrelated to brain activity in A1- men. Although these results require replication in a larger sample, alcohol-induced negative reinforcement may explain the greater risk for alcoholism associated with the A1 allele.


Assuntos
Encéfalo/efeitos dos fármacos , Depressores do Sistema Nervoso Central/farmacologia , Etanol/farmacologia , Polimorfismo Genético/efeitos dos fármacos , Proteínas Serina-Treonina Quinases/genética , Adulto , Alelos , Ansiedade/induzido quimicamente , Ansiedade/psicologia , Nível de Alerta/efeitos dos fármacos , Nível de Alerta/genética , Encéfalo/diagnóstico por imagem , Encéfalo/metabolismo , Mapeamento Encefálico , Depressores do Sistema Nervoso Central/sangue , Circulação Cerebrovascular/efeitos dos fármacos , Circulação Cerebrovascular/genética , Etanol/sangue , Fadiga/induzido quimicamente , Fadiga/psicologia , Fluordesoxiglucose F18 , Frequência do Gene , Glucose/metabolismo , Humanos , Masculino , Testes Neuropsicológicos , Tomografia por Emissão de Pósitrons/métodos , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/genética , Autoimagem , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...